Quantcast

Latest Celsion Corporation Stories

2015-02-23 08:28:53

Analysis of 285 Patient Subgroup Shows an Impressive Statistically Significant 59% Improvement in Overall Survival LAWRENCEVILLE, N.J., Feb.

2015-02-20 08:26:40

A Follow-On Combination Trial in First-Line Ovarian Cancer in the Neo-Adjuvant Setting Has Been Accepted by FDA LAWRENCEVILLE, N.J., Feb.

2015-01-06 08:32:02

Lead Immunotherapy Product Candidate GEN-1 to Enter Dose Escalating Clinical Study in the Second Half of 2015 LAWRENCEVILLE, N.J., Jan.

2014-11-11 08:30:26

Company Completes Acquisition and Integration of EGEN, Inc.; Enrollment Underway in Phase III OPTIMA Study; Initiates Phase II Euro-DIGINTY Study for RCW Breast Cancer; Establishes Clinical Study Plans

2014-10-29 08:33:08

Data Supportive of GEN-2, an RNAi Carrier for Therapeutic Treatment of Lung Cancer LAWRENCEVILLE, N.J., Oct.

2014-10-07 16:27:14

LAWRENCEVILLE, N.J., Oct. 7, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced that the Board of Directors has appointed Michael H.

2014-10-07 16:27:09

LAWRENCEVILLE, N.J., Oct. 7, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) is saddened to announce the passing of Max E.


Word of the Day
pawl
  • A pivoted catch designed to fall into a notch on a ratchet wheel so as to allow movement in only one direction (e.g. on a windlass or in a clock mechanism), or alternatively to move the wheel in one direction.
The word 'pawl' probably comes from a Latin word meaning 'stake'.
Related